Stocktoria
HeartSciences Inc. HSCS
Nasdaq · XNAS · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 2022-06-15
HeartSciences Inc. statistics & valuation
Market cap$9.7M
P / B47.1×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Gross margin | 56.8% | 67.3% | 45.7% | 45.1% |
| Operating margin | -192013.1% | -33902.0% | -118698.3% | -32765.6% |
| Net margin | -201499.5% | -35511.9% | -123384.3% | -33592.6% |
| FCF margin | -170486.2% | -32981.9% | -112463.8% | -25367.5% |
| Return on assets | -207.6% | -69.5% | -193.3% | -231.1% |
| Return on equity | -4272.2% | -90.3% | -2756.1% | 79.7% |
| Current ratio | 0.59 | 4.20 | 1.47 | 0.56 |
| Revenue growth | -76.6% | 261.2% | -64.2% | — |
Source: SEC EDGAR filings · CIK 0001468492 · as of 2025-04-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.